FDA Inspection 1236564 — Danielle R. Armas, MD
The FDA completed an inspection of Danielle R. Armas, MD on Apr 12, 2024 in Phoenix, AZ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Apr 12, 2024
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Phoenix, AZ (United States)
Additional Details
Clinical BA/BE